IJC Recap: Changes in MIGS Reimbursement, Monofocal IOL Technology, and Second-Generation Anti-VEGFs
1-4 of 4
IJC Recap: Changes in MIGS Reimbursement, Monofocal IOL Technology, and Second-Generation Anti-VEGFsIJC Recap: Changes in MIGS Reimbursement, Monofocal IOL Technology, and Second-Generation Anti-VEGFs
I. Paul Singh, MDI. Paul Singh, MD
IJC Recap: Changes in MIGS Reimbursement, Monofocal IOL Technology, and Second-Generation Anti-VEGFsExamining Changes in MIGS Reimbursement That Affect Procedural Selection
Sahar Bedrood, MD, PhDSahar Bedrood, MD, PhD
IJC Recap: Changes in MIGS Reimbursement, Monofocal IOL Technology, and Second-Generation Anti-VEGFsAdvancements in Monofocal IOL Technology
Julie Schallhorn, MDJulie Schallhorn, MD
IJC Recap: Changes in MIGS Reimbursement, Monofocal IOL Technology, and Second-Generation Anti-VEGFsSecond-Generation Anti-VEGFs in Age-Related Macular Degeneration
Carl D. Regillo, MD, FACS, FASRSCarl D. Regillo, MD, FACS, FASRS




